Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cannabidiol + red algae is a combination product consisting of two main components: **cannabidiol (CBD)**, a non-psychoactive cannabinoid from Cannabis sativa, and **red algae** extracts, typically derived from marine red algae species such as Lithothamnion calcareum. **Cannabidiol acts on multiple molecular targets** including cannabinoid receptors (CB1 and CB2), serotonin 5-HT1A receptors, TRPV1 channels, and several cytochrome P450 enzymes, leading to diverse effects including anxiolytic, anticonvulsant, antipsychotic, antioxidant, and immunomodulatory actions[1]. **Red algae** are primarily included in supplements for their mineral content (especially calcium and magnesium), bioactive polysaccharides, and potential anti-inflammatory effects; they are not known to directly target human proteins but may modulate inflammation and immune response through their polysaccharide and mineral components. This exact combination is marketed in some dietary supplements for claimed synergistic effects on joint health, inflammation, and overall wellness, but has not been established as a pharmaceutical preparation. Both components are extensively sold as dietary supplements but are not approved together as a pharmaceutical drug for any condition. The **mechanism of action** of the combination is presumed additive: CBD provides neuromodulation and anti-inflammatory effects through receptor interactions, while red algae supplies minerals and possible immune modulation[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cannabidiol + red algae.